key: cord-0882272-q3z7tbhi
authors: Śliwka, J.; Pawlak, S.; Danel, A.; Kowalski, R.; Wierzyk, A.; Grzybowski, A.; Przybyłowski, P.
title: Heart Transplantation as a Result of Pediatric Inflammatory Multisystem Syndrome in an Adolescent
date: 2022-04-08
journal: Transplant Proc
DOI: 10.1016/j.transproceed.2022.02.033
sha: 2fa4558f937cb1588b7624272995c6a55e86570f
doc_id: 882272
cord_uid: q3z7tbhi

Several reviews have shown that COVID-19 in children is a relatively mild disease. However, a rare complication affecting children and adolescents after COVID-19 has been identified. Pediatric inflammatory multisystem syndrome temporally associated with COVID-19 (PIMS-TS), which in some cases manifests itself as a hyperinflammatory syndrome with a multiorgan failure, may lead to death. We report a case of a 17-year-old patient who was admitted to the hospital with cardiogenic shock of unknown etiology. The disease was life-threatening, thus necessitating mechanical ventilation, circulatory support, and extracorporeal therapy due to renal and liver dysfunction. The patient tested negative for SARS-CoV-2 Reverse Transcription Polymerase Chain Reaction. Other infectious causes of illness were excluded. However, the patient had a positive IgG antibody test result and high levels of interleukin-6, which helped to diagnose PIMS-TS. Intravenous immunoglobulin and steroid therapies were initiated, unfortunately, with poor outcome. The patient's critical condition, particularly end-stage heart failure, led to mechanical circulatory support implantation and finally orthotopic heart transplantation. After the surgery, the patient's condition improved gradually. PIMS-TS manifests itself with different clinical images and as a state of varying severity, ultimately causing multiorgan dysfunction with shock resembling toxic shock syndrome. Ultimately, myocardial complications of PIMS-TS necessitated heart transplantation in the described patient.

C OVID-19 is an infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Initial reports suggested that SARS-CoV-2 infections among children and adolescents typically cause less severe illness and fewer deaths compared with adults [1] . In April 2020, clinicians noted a new phenomenon affecting children, potentially manifesting hyperinflammatory syndrome with multiorgan involvement, similar to Kawasaki disease shock syndrome [2] . This has been termed Pediatric Inflammatory Multisystem Syndrome (PIMS). We report the case of a child presenting multiple organ failure, leading to orthotopic heart transplantation (OHT), who was diagnosed with PIMS. A 17-year-old patient with a 3-month history of nonproductive, persistent cough, fever, nausea, and vomiting was admitted to the hospital in severe general condition. The patient presented tachycardia up to 180/min, tachypnea, centralization of circulation, and anuria. Due to suspicion of cardiogenic shock, transthoracic echocardiography (TTE) was performed, showing myocardial hypokinesis with left ventricle ejection fraction (LVEF) of 11% and symptoms of dilated cardiomyopathy of unknown etiology. Moreover, ultrasound revealed fluid in the right pleural cavity as well as in the abdominal cavity. Consequently, rapid-sequence intubation and mechanical ventilation were performed, and pressor amines therapy was initiated, but with poor results. The patient was supplied with venoarterial extracorporeal membrane oxygenation while being transported to a hospital of higher reference, where a Berlin Heart Excor left ventricular assist device and Levitronic right ventricular assist *Address Correspondence to: Joanna Sliwka Silesian Center for Heart Diseases ul. Sk»odowskiej-Curie 9 41-800 Zabrze, Poland, Tel: (+48) 501324251; Fax: (+48) 32 4793544. E-mail: jsliwka@sccs.pl device were placed. A month after the implantation of mechanical circulatory support, the patient's neurologic condition gradually deteriorated. Suspicion of ischemic stroke was confirmed by computed tomography angiography. During this time, efforts were made to establish the etiopathogenesis of the patient's condition. Laboratory results showed high leucocytosis and elevated inflammatory indicators: procalcitonin (16 ng/mL) and C-reactive protein (65 mg/L). PCR test results were negative. Other infectious agents were also excluded; thus, the diagnosis was extended to post-COVID-19. The patient had serologic evidence of infection (positive IgG antibody test results) and a high level of interleukin-6. Intravenous immunoglobulin and steroid therapies were initiated with no results. Due to severe renal failure, the patient was hemodiafiltrated, parenteral nutrition was introduced, and a tracheostomy was performed. After improvement in right ventricular function, the right ventricular assist device was removed. Due to lack of evidence of cardiac regeneration, after stabilization of renal and hepatic function, the boy was listed for an urgent heart transplant. He was given a successful transplant on the 56th day of hospitalization. After the procedure, the patient's general condition improved. To assess cardiac allograft function, TTE was performed, showing normal left ventricular function with LVEF of 75%. Three months after OHT, the patient presented with generalized tonic-clonic seizures with the dynamics of Jacksonian march. After a loading dose of valproic acid had no effect on the seizures, diazepam was administered intravenously. Control computed tomography scans in relation to the previous study revealed the evolution of large ischemic areas with no fresh lesions. In the long term, management maintained dual-drug immunosuppressive therapy based on cyclosporine and Encorton. During hospitalization, the patient was under intensive holistic care, including rehabilitation and continuous supervision by a psychologist. On follow-up, 7 months after OHT, features of persistent left-sided hemiparesis were present. A scheduled endomyocardial biopsy showed no evidence of transplant rejection. Control TTE showed normal LVEF of 60%. Levels of immunosuppressants were maintained within the therapeutic range.

The reported clinical image meets the criteria of PIMS published by the Royal College of Paediatrics and Child Health [3] . On the day of admission to the hospital, the patient presented with persistent fever, gastrointestinal symptoms including vomiting, mild respiratory disorder, and laboratory evidence of inflammation. His clinical condition worsened over the following days, and the development of multiorgan dysfunction was obvious. The patient required mechanical ventilation, and circulation was supported by vasopressors with poor effect. Renal and liver function needed to be replaced with extracorporeal therapy. Evidence of SARS-CoV-2 infection was confirmed with reactive IgG antibodies and high levels of interleukin-6. PIMS manifests in different ways and with varying severity, ultimately causing multiorgan failure, which necessitated a heart transplant in the described patient. The literature describes different phenotypes of the disease: Kawasaki disease-like, nonspecific Kawasaki disease-like, macrophage activation syndrome, or toxic shock syndrome (TSS) [4] . Cytokine storm in TSS is a crucial factor in symptoms such as high fever, hyperinflammation, and multiorgan involvement, but these symptoms are commensurate with PIMS. It has been proven that the binding of epitopes on SARS-CoV-2 spikes exhibits superantigenic character, which can lead to the development of a systemic disease. Similarity to mechanisms widely described for TSS explains a comparable picture in both syndromes and could be used as a diagnostic tool. Every patient with suspected PIMS requires a multidisciplinary team approach. Treatment strategies aim at reversing the inflammatory response using immunomodulatory medications. Intravenous immunoglobulin is the first-line therapy; intravenous methylprednisolone should be considered as the next treatment option, as well as biological therapy [3] . Most children diagnosed with PIMS recover within days to a couple of weeks. Mortality is rare, although more information is needed about medium-and long-term sequelae, particularly cardiovascular complications.

The data that has been used is confidential.

Systematic review of COVID-19 in children shows milder cases and a better prognosis than adults

Hyperinflammatory shock in children during COVID-19 pandemic

PIMS-TS National Consensus Management Study Group. A national consensus management pathway for paediatric inflammatory multisystem syndrome temporally associated with COVID-19 (PIMS-TS): results of a national Delphi process

Pediatric Inflammatory Multisystem Syndrome (PIMS) Did Occur in Poland during Months with Low COVID

Preliminary Results of a Nationwide Register